Deciphar Life Sciences Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-07-2024
- Paid Up Capital ₹ 0.10 M
as on 11-07-2024
- Company Age 23 years 3 months
- Last Filing with ROC 31 Mar 2023
- Revenue %
FY 2020
- Profit -35.90%
FY 2020
- Ebitda 58.01%
FY 2020
- Net Worth -0.59%
FY 2020
- Total Assets 10.16%
FY 2020
About Deciphar Life Sciences
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per the Ministry of Corporate Affairs (MCA) records.
Chandrasekhar Nair and Sangeetha Sriram serve as directors at the Company.
- CIN/LLPIN
U74140KA2001PTC029114
- Company No.
029114
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Deciphar Life Sciences?
Board Members(2)
Financial Performance and Corporate Structure Insights of Deciphar Life Sciences.
Deciphar Life Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 35.9% decrease in profit. The company's net worth dipped by a decrease of 0.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deciphar Life Sciences?
In 2019, Deciphar Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Coreintegra Consulting Services Private Limited
Active
15 years 5 months Sangeetha Sriram is a mutual person
Molbio Diagnostics Private Limited
Active 23 years 11 months Chandrasekhar Nair and Sangeetha Sriram are mutual person
Eureka Outsourcing Solutions Private Limited
Active 22 years 4 months Sangeetha Sriram is a mutual person
Bigtec Private Limited
Active 28 years 2 months Chandrasekhar Nair and Sangeetha Sriram are mutual person
Prognosys Healthcare (India) Private Limited
Active 9 years 7 months Chandrasekhar Nair is a mutual person
Prognosys Medical Systems Private Limited
Active 20 years 10 months Chandrasekhar Nair is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Deciphar Life Sciences?
Unlock and access historical data on people associated with Deciphar Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deciphar Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deciphar Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
